| Literature DB >> 35217816 |
Kristine Griffett1, Matthew E Hayes2, Michael P Boeckman1, Thomas P Burris3.
Abstract
REV-ERBs are atypical nuclear receptors as they function as ligand-regulated transcriptional repressors. The natural ligand for the REV-ERBs (REV-ERBα and REV-ERBβ) is heme, and heme-binding results in recruitment of transcriptional corepressor proteins such as N-CoR that mediates repression of REV-ERB target genes. These two receptors regulate a large range of physiological processes including several important in the pathophysiology of non-alcoholic steatohepatitis (NASH). These include carbohydrate and lipid metabolism as well as inflammatory pathways. A number of synthetic REV-ERB agonists have been developed as chemical tools and they show efficacy in animal models of NASH. Here, we will review the functions of REV-ERB with regard to their relevance to NASH as well as the potential to target REV-ERB for treatment of this disease.Entities:
Keywords: Heme; NASH; REV-ERB; circadian clock; inflammation; lipid and glucose metabolism
Mesh:
Substances:
Year: 2022 PMID: 35217816 PMCID: PMC9061770 DOI: 10.1038/s41401-022-00883-w
Source DB: PubMed Journal: Acta Pharmacol Sin ISSN: 1671-4083 Impact factor: 7.169